首页|不同中医证型胃癌患者外周血miR-21、miR-122水平变化及临床意义

不同中医证型胃癌患者外周血miR-21、miR-122水平变化及临床意义

扫码查看
目的:观察探讨不同中医证型胃癌(GC)患者外周血miR-21、miR-122水平变化及临床意义.方法:选取2022年1月~2023年1月我院收治的100例GC患者为研究对象,根据其临床表现和体征进行中医证型分型,比较不同中医证型GC患者外周血miR-21、miR-122水平、毒副反应发生率及化疗半年后的存活情况.结果:100例GC患者中47例为脾胃湿热证,17例为脾胃虚寒证,15例为肝胃不和证,13例为瘀血内阻证,8例为痰浊凝滞证.不同中医证型GC患者外周血miR-21水平为脾胃湿热证>脾胃虚寒证>肝胃不和证>瘀血内阻证>痰浊凝滞证,miR-122水平为脾胃湿热证<脾胃虚寒证<肝胃不和证<瘀血内阻证<痰浊凝滞证,且两组间比较差异均有统计学意义(P<0.05).脾胃湿热证患者胃肠道反应和骨髓抑制发生率明显高于痰浊凝滞证和瘀血内阻证(P<0.05),神经系统反应及肾损害发生率明显高于瘀血内阻证(P<0.05);脾胃虚寒证患者骨髓抑制发生率明显高于痰浊凝滞证和瘀血内阻证(P<0.05),神经系统反应发生率明显高于瘀血内阻证(P<0.05);肝胃不和证患者神经系统反应发生率明显高于瘀血内阻证(P<0.05).不同中医证型GC患者化疗后随访6个月的生存率为脾胃湿热证<脾胃虚寒证<肝胃不和证<瘀血内阻证<痰浊凝滞证,但组间比较差异均无统计学意义(P>0.05).结论:不同中医证型GC患者外周血miR-21、miR-122表达存在差异,检测二者水平对评估患者病情进展及预后有一定价值.
Changes and clinical significance of miR-21and miR-1221evels in peripheral blood of patients with gastric cancer of different TCM syndromes types
Objective:To observe the changes and clinical significance of peripheral blood miR-21and miR-122levels in patients with gastric cancer(GC)of different TCM syndromes types.[Methods]100patients with GC admitted to our hospital were selected as the research subjects from January 2022to January 2023.According to the clinical manifestations and signs,the patients were classified by TCM syndromes types.The levels of peripheral blood miR-21and miR-122,incidence rates of toxic and side effects and survival after half a year of chemotherapy were compared among GC patients with different TCM syndromes types.[Results]Among the 100patients with GC,there were 47cases of spleen-stomach damp-heat syndrome,17cases of spleen-stomach deficiency-cold syndrome,15cases of liver-stomach disharmony syndrome,13cases of blood stasis internal bloc-king syndrome and 8cases were phlegm-turbidity stagnation syndrome.The level of miR-21in peripheral blood of GC patients with different TCM syndromes types was shown as spleen-stomach damp-heat syndrome>spleen-stomach deficiency-cold syndrome>liver-stomach disharmony syndrome>blood stasis internal blocking syndrome>phlegm-turbidity stagnation syndrome,while the level of miR-122was manifested as spleen-stomach damp-heat syndrome<spleen-stomach deficiency-cold syndrome<liver-stomach disharmony syndrome<blood stasis internal blocking syndrome<phlegm-turbidity stagnation syndrome(P<0.05).The incidence rates of gastrointestinal reaction and bone marrow suppression in patients with spleen-stomach damp-heat syndrome were significantly higher than those in patients with phlegm-turbidity stagnation syndrome and blood stasis internal blocking syn-drome(P<0.05),and the incidence rates of nervous system reaction and renal damage were significantly higher than those in pa-tients with blood stasis internal blocking syndrome(P<0.05).The incidence rate of bone marrow suppression was significantly higher in patients with spleen-stomach deficiency-cold syndrome than that in patients with phlegm-turbidity stagnation syndrome and blood stasis internal blocking syndrome(P<0.05),and the incidence rate of nervous system reaction was also significantly higher than that in patients with blood stasis internal blocking syndrome(P<0.05).The incidence rate of nervous system reaction was significantly higher in patients with liver-stomach disharmony syndrome than that in patients with blood stasis internal bloc-king syndrome(P<0.05).The survival rate of GC patients with different TCM syndromes types after 6months of follow-up after chemotherapy revealed spleen-stomach damp-heat syndrome<spleen-stomach deficiency-cold syndrome<liver-stomach dis-harmony syndrome<blood stasis internal blocking syndrome<phlegm-turbidity stagnation syndrome,but there was no significant difference between the groups(P>0.05).[Conclusion]There are differences in the expressions of miR-21and miR-122in pe-ripheral blood of GC patients with different TCM syndromes types.The detection of the two levels has certain value on evaluating the disease progression and prognosis of patients.

Gastric cancerTCM syndromes typesmiR-21miR-122ChemotherapyToxic and side effectsPrognosis

廖茂杉、黄江华、杨涛、宋娟

展开 >

川北医学院附属三台医院检验科,四川三台 621100

胃癌 中医证型 miR-21 miR-122 化疗 毒副反应 预后

2024

四川中医
四川省中医药学会,四川省中西医结合学会,四川省针灸学会,四川省中医药科学院

四川中医

CSTPCD
影响因子:0.522
ISSN:1000-3649
年,卷(期):2024.42(4)
  • 16